Lifecore Biomedical Inc
LFCR
Get informed when a big investor buys or sells
+ FollowMarket Cap$241.94M
Close$
$7.04
9.4% upside
Current Fair Value
9.4% upsideUndervalued by 9.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $241.94 Million |
|---|---|
| Enterprise Value | $385.04 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.92 |
| Beta | 0.98 |
| Outstanding Shares | 37,574,538 |
Return
| Return on Equity | -167.50% |
|---|---|
| Return on Assets | -11.75% |
| Return on Invested Capital | 5.25% |
Valuation & Multiples
| P/E Ratio | -5.86 |
|---|---|
| PEG | 4.62 |
| Price to Sales | 2.15 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.11 |
| Enterprise Value to EBIT | 35.28 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 9.96 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 2, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$25.96 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.30
Average shareholder expectationRevenue Estimate
$25.57 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 33.55% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 68.04% |
|---|---|
| Total Invested | $13,476▼ 99.99% |
| Investors Holding | 3▼ 101.00% |
ESG Score
No data
About Lifecore Biomedical Inc
796 employees
CEO: Albert Bolles Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the foo...